Cardiff Oncology, Inc. (CRDF): Shares Outstanding

Annual figures by period end, from SEC filings.

Stock splits: 1-for-12, first reflected in a filing dated 2018-08-03. Figures are as filed: per-share figures and share counts last reported before a split are on the old share basis, so changes and growth rates across a split are not shown. Splits are read from the filings' own restatements, so a share conversion in a merger or reorganization shows up the same way.

68.31M
As of 2025-12-31
68.50M
As of 2026-06-30
2011-12-31: 10.74M2012-12-31: 15.48M2013-12-31: 18.90M2014-12-31: 18.92M2015-12-31: 29.74M2016-12-31: 30.70M2017-12-31: 733.2K2018-12-31: 3.83M2019-12-31: 8.59M2020-12-31: 36.78M2021-12-31: 41.96M2022-12-31: 44.68M2023-12-31: 44.68M2024-12-31: 66.52M2025-12-31: 68.31M68.31M
2011-12-31 Shares Outstanding (shares) 2025-12-31

Paler bars were last filed before a stock split, on the old share basis.

Period endedShares OutstandingChange YoYSource filing
2025-12-3168.31M+2.7%2026-02-24, Balance as of period end
2024-12-3166.52Mn/c2026-02-24, Balance as of period end
2023-12-3144.68M0.0%2025-02-27, Balance as of period end
2022-12-3144.68M+6.5%2024-02-29, Balance as of period end
2021-12-3141.96M+14.1%2023-03-02, Balance as of period end
2020-12-3136.78M+328.0%2022-02-24, Balance as of period end
2019-12-318.59M+124.3%2021-02-25, Balance as of period end
2018-12-313.83Mn/c2020-02-27, Balance as of period end
2017-12-31733.2Kn/c2019-03-06, Balance as of period end
2016-12-3130.70M+3.2%2018-02-26, Balance as of period end
2015-12-3129.74Mn/c2017-03-15, Balance as of period end
2014-12-3118.92M+0.1%2016-03-10, Balance as of period end
2013-12-3118.90M+22.1%2015-03-12, Balance as of period end
2012-12-3115.48Mn/c2014-03-17, Balance as of period end
2011-12-3110.74Mn/a2013-04-01, Balance as of period end